Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Telmisartan for COVID-19 Complications
NCT04360551Phase 2Terminated
- Sponsor
- University of Hawaiʻi
- Start
- Jul 2020
- Primary completion
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of telmisartan in coronavirus disease 2019 (COVID-19), sponsored by University of Hawaiʻi. Started Jul 2020; status: terminated.
02
Drugs
telmisartan
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04360551.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04360551.